$2.26
-0.01 (-0.44%)
Open$2.29
Previous Close$2.27
Day High$2.34
Day Low$2.20
52W High$4.75
52W Low$1.27
Volume—
Avg Volume191.7K
Market Cap84.93M
P/E Ratio5.44
EPS$0.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+639.4% upside
Current
$2.26
$2.26
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 195.28M | 185.60M | 22.38M |
| Net Income | 27.48M | 23.50M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 38.15M | 34.44M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |